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ABSTRACT 
Objectives: The aim of the present study was to isolate, characterize and evaluate the activity of compounds produced by Streptomyces 
cheonanensis VUK-A. 
Methods: Chemical examination of the secondary metabolites of the strain Streptomyces cheonanensis VUK-A has led to the segregation of one 
bioactive compound (1) and a partially purified fraction (2). The strain was isolated from the sediment samples of mangrove ecosystem of Coringa, 
south coastal Andhra Pradesh, India. The chemical structure of the active compound 1 was established on the basis of spectroscopic analysis 
including 1H NMR, 13C NMR spectroscopy, FTIR and EIMS. The partially purified sub-fraction (2) subjected to Gas Chromatography-Mass 
spectroscopy. The antimicrobial activity of the bioactive compounds produced by the strain was expressed in terms of minimum inhibitory 
concentration. 
Results: The compound 1 was isolated from the fermentation broth was characterized as benzoic acid (1) based on spectroscopic analysis. The 
partially purified sub-fraction (2) subjected to Gas Chromatography-Mass spectroscopy contained nine analogues: 1-tetradecene, tetradecane, 1-
hexadecene, hexadecane, 5-octadecene, octadecane, 5-eicosene, 1-nonadecene and cyclo tetracosane. The compounds recorded moderate to 
significant antimicrobial activity against medicinally and agriculturally important bacteria and fungi. This is the first report of six partially purified 
compounds 1-tetradecene, tetradecane, hexadecane, octadecane, 5-eicosene and cyclo tetracosane from the genus Streptomyces. 
Conclusion: The results of the present study showed that the metabolites of Streptomyces cheonanensis VUK-A exhibited antibacterial and 
antifungal activities. The study also supports that Coringa, a promising mangrove ecosystem remained to be explored for new bioactive compounds.  
Keywords: Streptomyces cheonanensis, Mangrove Ecosystem, Natural Products, Antimicrobial activity. 
 
INTRODUCTION 
The probe for new potent compounds with novel and specific mode 
of action to combat against emerging infectious diseases and 
antibiotic resistant pathogens presumed to be major health concern 
challenging the entire world is to be addressed on a war footing. 
Secondary metabolites of the actinobacteria are endowed with a 
wide variety of chemical structures possessing strong biological 
activities and gain attention in view of their positive therapeutic 
effects to human health [1]. Actinobacteria are a diverse group of 
microorganisms that are widely distributed in terrestrial, freshwater 
and marine habitats [2], outnumber of studies on the terrestrial 
actinobacteria have been carried out when compared to the marine 
habitats. Mangrove swamps are important constituents of the 
marine ecosystem [3] and subjected to ever-changing abiotic factors 
such as high salinity, high temperature, extreme tides, high 
evaporation and high sedimentation [4]. Mangrove ecosystems 
remain largely unexplored and offer an excellent opportunity for 
isolating the potent actinomycetes with solitary properties capable 
of producing many useful bioactive compounds such as antibiotics, 
therapeutic enzymes and antitumour agents [5].  
The actinobacteria of the mangrove origin can produce secondary 
metabolites with diverse chemical skeleton and potent biological 
activities have been playing an extensive role in pharmaceutical and 
medical industry. Thousands of purified bioactive compounds have 
been characterized and become a part and parcel in the 
development of drugs to treat a wide range of diseases in human, 
veterinary and agriculture sector [6]. Reports have been well 
documented that each actino bacterial strain has genetically 
potential to produce 10 to 20 secondary metabolites [7] and hence 
are considered not only as indispensable novel antibiotic producers 
but also play a promising defence role by inhibiting the other 
competing cells and make available more nutrients to the metabolite 
producing strain for survival [8].  
Streptomyces generally are an acknowledged group of microbes can 
generate a lot of different wide spectrum bioactive compounds [9]. 
Streptomyces species account to 74% while the rare genera of 
actinobacteria to 26% of the total bioactive compounds isolated 
[10]. Streptomyces produce the most diverse, unprecedented, often 
very complicated compounds displaying exceptional antibacterial 
potency with usually minimal toxicity. The factors contributing to 
their diverse metabolic diversity are due to the extremely large 
genome that carries hundreds of regulatory factors to regulate the 
gene expression in response to specific needs [11]. Streptomyces has 
special role in the antibiotic production and yielded many therapeutic 
agents which include antibacterial, antifungal and anticancer drugs 
like Tetracycline, Amphotericin B and Asriamycin. Streptomyces spp. is 
widely recognized as industrially important microorganisms for their 
ability to yield different kinds of new secondary metabolites [12]. 
Many reports have endorsed the importance of the pharmaceutical 
activity of Streptomyces obtained from different habitats, but only a 
few reports are available to deal with the industrially important 
Streptomyces from mangrove ecosystem [13]. As a part of our 
present research for useful bioactive metabolites, we observed that 
the actinomycetes strain VUK-A which was isolated from unexplored 
mangrove sediment samples of Coringa, South coastal Andhra 
Pradesh, India showed broad spectrum antimicrobial activity and 
also investigated the active constituents of actinobacterium.  
MATERIALS AND METHODS 
Isolation 
The actinomycetes strain, VUK-A was isolated from the Coringa 
mangrove ecosystem by employing soil dilution plate technique on 
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starch casein agar medium. The strain was identified as 
Streptomyces cheonanensis by cultural, morphological, physiological 
and biochemical studies along with the 16S rRNA analysis. The rRNA 
sequence was deposited in the NCBI Genbank with an accession 
number JN087502. The strain was maintained on yeast extract-malt 
extract dextrose (YMD) agar medium at 4 ˚ C for further study. 
Purification and structural elucidation of bioactive metabolites 
The twin activities i.e. isolation and identification of bioactive 
metabolites, a loopful culture of Streptomyces cheonanensis VUK-A 
was cultivated in YMD broth (seed broth) and incubated on a rotary 
shaker (250 rpm) at 35˚C. After 48 h incubation, the seed culture at 
the rate of 10% was transferred to the optimized fermentation 
medium consisting of lactose (1%), peptone (0.5%), K2HPO4 
(0.05%), FeSO4 (0.001%) and NaCl (3%) with pH adjusted to 7.0 
[14]. The culture filtrates (20 L) obtained after cultivation of the 
strain for 96 h were extracted twice with ethyl acetate and 
concentrated in a rotavap, and freeze dried to yield a dark green 
residue. The weight of total crude extract was 2.5 g. The dark green 
crude residue (2.5g) was loaded on a silica gel column (25Χ 5 cm, 
Silica gel 100, Merck, Mumbai, India) and eluted successively with 
200 ml of 100% hexane, 200 ml of linear gradient hexane: ethyl 
acetate (v/v, 75:25-25:75), 200 ml of 100% ethyl acetate and finally 
with 200 ml of 100% methanol resulting in six fractions, 5 polar 
residues and one non-polar residue. Among the five polar fractions, 
fraction IV and the single non-polar fraction (PPF) exhibited high 
antimicrobial activity. The fraction IV (700 mg) was selected for 
further studies and subjected to silica gel column chromatography 
(100-200 mesh), which afforded fractions 1-5. Based on TLC 
monitoring and NMR spectral data, the subfraction 3 was selected 
for further purification. The active subfraction 3 (280 mg) was 
subjected to further purification by silica gel column 
chromatography using 30% ethyl acetate and yielded compound 1 
(36 mg). The purity of the compound was checked using TLC and 
structure of the active compound was elucidated and confirmed on 
the basis of FTIR, mass and NMR spectroscopic data. 
The components of the partially purified fraction (PPF) (2) were 
analysed on Agilent GC-MS system (GC: 5890 series II; MSD 5972). 
The fused silica HP-5 capillary column (30 m x 0.25 mm, ID, film 
thickness of 0.25 μm) was directly coupled to the MS. The carrier gas 
was helium with a flow rate of 1.2 ml min-1. Oven temperature was 
programmed (50˚C min-1, then 50-280˚C at a rate of 5̊ C min-1) and 
subsequently, held isothermally for 20 min. The temperature of the 
injector port was maintained at 250 ˚C and that of the detector at 
280 ˚C [15]. The peaks of components in gas chromatography were 
subjected to mass spectral analysis. The spectra were analysed from 
the available library data; NIST MS search (ver. 2.0). (Included with 
NIST’02 mass spectral library, Agilent p/n G1033A). 
Test microorganisms 
Gram-positive bacteria: Bacillus cereus (MTCC 430), Streptococcus 
mutans (MTCC 497), Staphylococcus aureus (MTCC 3160), 
Staphylococcus epidermis (MTCC 120), Bacillus subtilis (ATCC 6633), 
Bacillus megaterium (NCIM 2187); Gram-negative bacteria: 
Escherichia coli (ATCC 35218), Pseudomonas aeruginosa (ATCC 
9027), Proteus vulgaris (MTCC 7299), Serratia marcescens (MTCC 
118), Xanthomonas campestris (MTCC 2286), Xanthomonas 
malvacearum (NCIM 2954) and Salmonella typhi (ATCC 14028); 
Medically important dermatophytes: Candida albicans (ATCC 10231) 
and Epidermophyton floccosum (MTCC 145); Medically and 
agriculturally important filamentous fungi: Aspergillus niger (ATCC 
1015), Aspergillus flavus (ATCC 9643), Fusarium oxysporum (MTCC 
3075), Fusarium solani (MTCC 4634), Penicillum citrinum (MTCC 
6489), Verticillium alboatrum and Alternaria alternata (MTCC 6572). 
The test microorganisms used in the present study were procured 
from ATCC, University Boulevard, Manassas, USA and MTCC, 
Chandigarh, NCIM, Pune, India and preserved at 4 C̊. 
Minimum inhibitory concentration (MIC) assay 
The antimicrobial spectra of the bioactive compounds of the strain 
were determined in terms of minimum inhibitory concentration 
(MIC) against a wide variety of gram-positive and gram-negative 
bacteria and fungi by using the agar plate diffusion assay [16]. 
Triplicate sets of the plates were maintained for each concentration 
of the test sample. Muller-Hinton agar and Czapek-Dox agar media 
were prepared to grow the bacteria and fungi, respectively. The 
purified compounds were dissolved in dimethyl sulfoxide at 
concentrations ranging from 0 to 1000 μg/ml and used to assay 
against supra mentioned test bacteria and fungi. The inoculated 
plates were examined after 24-48 h of incubation at 37 ° C for 
bacteria and 48-72 h at 28 °C for fungi. The lowest concentration of 
the bioactive metabolites exhibiting significant antimicrobial activity 
against the test microorganisms was taken as the MIC of the 
compound. 
RESULTS AND DISCUSSION 
Culture filtrates obtained after 96 h fermentation were extracted 
with ethyl acetate and concentrated to yield a dark green residue, 
which in turn was subjected to silica gel column chromatography 
using a gradient solvent system of hexane: ethyl acetate. Among the 
six fractions collected the fraction IV and a non-polar partially 
purified fraction (PPF) exhibiting good antimicrobial activity. The 
fraction IV was rechromatographed on a silica gel column and 
yielded five fractions. Further purifications of active sub-fraction 3 
by sequential chromatographic purification on silica gel yielded 
compound 1. The components of partially purified non-polar 
fraction were analysed by using GC-MS. 
 
 
Fig. 1A: 1H NMR spectrum of compound (1), 1B: 13C NMR spectrum of compound (1), 1C: Mass spectrum of compound (1), 1D: FTIR 
spectrum of compound (1) 
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Compound (1) was obtained as a colourless crystalline solid, freely 
soluble in ethanol and partially in benzene, acetone and water. The 
1H-NMR spectrum of the compound showed signals at δ6.89 (m, 2H); 
6.37 (m, 1H) and 6.22 (m, 2H) (fig. 1A), while 13C exhibited 5 signals 
at δ 172.5; 133.78; 130.19 (2C); 129.32 and 128.45 (2C) (fig. 1B). 
EIMS analysis of the compound gave a molecular ion m/z at 145 
[M+Na]+ (fig. 1C) The IR spectrum displayed absorption band at V max 
1695 cm-1suggested the presence of functional groups like carboxyl 
groups (fig. 1D). Based on the above spectral data, bioactive 
compound 1 was identified as Benzoic acid (fig. 2) with the 
molecular formula of C7H6O2. 
 
Fig. 2: Molecular structure of benzoic acid (1) 
 
Analysis of the components of partially purified subfraction (PPF) 
(2) by GC (fig. 3) implied nine peaks at the retention times of 15.01 
min (A), 15.13 min (B), 18.13 min (C), 18.23 min (D), 20.93 min (E), 
21.01 min (F), 23.47 min (G), 25.79 min (H) and 28.01 min (I). 
Further examination of these peaks by MS showed molecular ions 
M+at m/z 196, 198, 224, 226, 234, 254, 260, 247 and 370 
respectively (data not shown). According to the available library 
data, NIST MS search (ver. 2.0) (Included with NIST’02 mass spectral 
library, Agilent p/n G1033 A), compounds viz., A, B, C, D, E, F, G, H 
and I present in partially purified fourth subfraction were 
tentatively identified as 1-tetradecene, tetradecane, 1-hexadecene, 
hexadecane, 5-octadecene, octadecane, 5-eicosene, 1-nonadecene 
and cyclo tetracosane respectively. 
Minimum inhibitory concentration (MIC) assay 
Antibacterial activities of the bioactive compounds (1 and 2) in 
terms of MIC are shown in table 1. The bioactive compounds 
exhibited antibacterial activity against a variety of gram-positive and 
gram-negative bacteria, for which the MIC values ranged from 16 to 
256 μg/ml. Among the opportunistic and Gram-positive pathogenic 
bacteria, compound 1 was active against all the bacteria tested, and 
the best activity of this compound was recorded against Bacillus 
subtilis (16 μg/ml). The fraction 2 (PPF) presented the highest 
activity against Staphylococcus aureus and Staphylococcus epidermis 
(32 μg/ml). Of the Gram-negative bacteria, the microorganisms that 
presented the highest sensitivity towards compound 1 was Serratia 
marcescens (32 μg/ml) followed by Escherichia coli (64 μg/ml). 
Fraction 2 (PPF) recorded the highest activity against Xanthomonas 




Fig. 3: GC-spectra of a partially purified fourth subfraction (PPF) 
of Streptomyces cheonanensis VUK-A. By means of mass spectral 
analysis, the compounds (A, B, C, D, E, F, G, H and I) with retention 
time 15.01, 15.13, 18.13, 18.23, 20.93, 21.01, 23.47, 25.79 and 
28.01 in PPF were identified as 1-tetradecene, tetradecane, 1-
hexadecene, hexadecane, 5-octadecene, octadecane, 5-eicosene, 
1-nonadecene and cyclo tetracosane respectively 
 
Tetracycline served as positive control for bacteria. Compared to 
standard drug tetracycline, 1 displayed high sensitivity against 
Bacillus subtilis, while 2 (PPF) recorded similar sensitivity like 
positive control against Staphylococcus aureus and Xanthomonas 
campestris (table 1). Tetracycline, in other cases, showed good 
antibacterial activity over the metabolites of the strain. 
 
Table 1: Minimum inhibitory concentration (μg/ml) of the bioactive compounds produced by Streptomyces cheonanensis VUK-A against 
gram positive and gram negative bacteria 
Test microorganisms  Compound-1  Compound-2 Tetracycline (Control) 
 Zone of 
Inhibition 
±SD P value Zone of 
Inhibition 
±SD P value Zone of 
Inhibition 
±SD P value 
Staphylococcus aureus 64.00 ±0.54  (p<0.01)  32.00 ±0.43  (p<0.02) 32.00 ±0.39  (p<0.03) 
Streptococcus mutans 128.00 ±0.31  (p<0.03) 64.00 ±0.51  (p<0.01) 32.00 ±0.68  (p<0.03) 
S. epidermis 128.00 ±0.46  (p<0.02)  32.00 ±0.39  (p<0.04) 16.00 ±0.32  (p<0.03) 
X. campestris 256.00 ±0.69  (p<0.04) 16.00 ±0.63  (p<0.05) 16.00  ±0.71  (p<0.02) 
X. malvacearum 128.00   0.43   p<0.01)  32.00 ±0.48   p<0.03)  8.00 ±0.47   p<0.02) 
Bacillus subtilis 16.00  ±0.51  (p<0.05) 64.00  ±0.21  (p<0.02) 32.00  ±0.56  (p<0.04) 
B. megaterium 128.00  ±0.37  (p<0.01) 64.00  ±0.48  (p<0.02) 16.00  ±0.52  (p<0.05) 
B. cereus  64.00  ±0.72  (p<0.02) 64.00  ±0.39  (p<0.04) 8.00  ±0.31  (p<0.01) 
Escherichia coli  64.00  ±0.42  (p<0.04) 32.00  ±0.63  (p<0.02) 8.00  ±0.46  (p<0.04) 
P. aeruginosa 32.00  ±0.54  (p<0.03) 128.00  ±0.47 (p<0.03) 8.00  ±0.39  (p<0.03) 
Serratia marcescens 32.00  ±0.54  (p<0.03) 64.00  ±0.39  (p<0.04) 32.00  ±0.62  (p<0.03) 
Proteus vulgaris  256.00  ±0.51  (p<0.05) 128.00  ±0.39 (p<0.05) 16.00  ±0.49  (p<0.05) 
Salmonella typhi ND ND ND 128.00 ±0.41 (p<0.01) 8.00 ±0.47  (p<0.05) 
Values are mean±SD (n=3) 
The above components are subjected to one-way analysis of variance (ANOVA) tested 5% level of significance. All the values are found to be 
significant (p<0.05), Compound 1: Benzoic acid, Compound 2: Partially purified fraction (PPF), Tetracycline: control, ND: Not detected 
 
Antifungal activity against dermatophytes and filamentous fungi and 
corresponding MIC values are recorded in table 2. The bioactive 
compounds showed low antifungal activity against the 
dermatophytes (Candida albicans and Epidermophyton floccosum) 
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and the tested fungi. Among the filamentous fungi tested, Aspergillus 
flavus and Penicillium citrinum recorded sensitivity of 64 μg/ml 
towards compound 1 and no activity was recorded against 
Verticillium alboatrum and Alternaria up to 1000 μg/ml. PPF was 
active against Aspergillus flavus at 16 μg/ml followed by Fusarium 
solani (32 μg/ml) and displayed similar sensitivity like positive 
control against Fusarium solani. In other cases, both compounds 
recorded lower antifungal activity than the standard fungicides such 
as Griseofulvin against dermatophytes and Amphotericin-B against 
fungi. 
 
Table 2: Minimum inhibitory concentration (MIC) of the bioactive compounds isolated from Streptomyces cheonanensis VUK-A (MIC-
(μg/ml)) against dermatophytes and fungi 
Dermatophytes Compound-1  Compound-2 Anti-fungal agent (Control) 
 Zone of 
Inhibition 
±SD P value Zone of 
Inhibition 
±SD P value Zone of 
Inhibition 
±SD P value 
Candida albicans 64.00 ±0.36  (p<0.01)  64.00 ±0.68  (p<0.01) 16.00 ±0.46  (p<0.01) 
Epidermophyton 
floccosum 
128.00 ±0.47  (p<0.02) 64.00 ±0.28  (p<0.02) 16.00 ±0.51  (p<0.02) 
Fungi  
Aspergillus niger 128.00 ±0.36  (p<0.05) 64.00 ±0.43  (p<0.03) 16.00  ±0.76  (p<0.04) 
Aspergillus flavus 64.00 ±0.45   p<0.02) 16.00 ±0.44   p<0.04) 8.00 ±0.39   p<0.04) 
Fusarium oxysporum 256.00 ±0.57  (p<0.03) 128.00  ±0.27  (p<0.01) 16.00  ±0.21  (p<0.02) 
Fusarium solani 128.00 ±0.63  (p<0.05) 32.00  ±0.37  (p<0.01) 32.00  ±0.43  (p<0.03) 
Penicillium citrinum 128.00 ±0.37  (p<0.05) 64.00  ±0.63  (p<0.03) 8.00  ±0.69  (p<0.02) 
Verticillium alboatrum ND ND  ND 128.00  ±0.57  (p<0.03) 64.00  ±0.59  (p<0.05) 
Alternaria alternata ND ND  ND 256.00  ±0.37 (p<0.02) 32.00  ±0.31  (p<0.01) 
Values are mean±SD (n=3) 
The above components are subjected to one-way analysis of variance (ANOVA) tested 5% level of significance. All the values are found to be 
significant (p<0.05), (p<0.05), Compound 1: Benzoic acid, Compound 2: Partially purified fraction (PPF), ND: Not detected 
*Antifungal agent: Griseofulvin (Control) against dermatophytes and Amphotericin-B (control) against fungi 
 
The bioactive compounds of the present work extracted from 
Streptomyces cheonanensis VUK-A, showed moderate to significant 
antimicrobial activity against opportunistic and pathogenic bacteria 
and fungi. The active compound produced by the strain VUK-A was 
benzoic acid. Benzoic acid and its derivatives are the natural 
constituents of many plants and microorganisms. Benzoic acid was 
effective against bacteria in acid media at a level of 0.1% and in 
neutral media at 0.2% but inactive in alkaline media. Benzoic acid 
under appropriate conditions act as bactericidal and bacteriostatic 
agent and sodium benzoate inhibited the growth of Vibrio 
parahaemolyticus and Listeria monocytogenes [17, 18]. Similar 
results were reported for fungi and yeasts [19]. We have observed 
that compound 1 showed significant inhibitory activities against 
Bacillus subtilis (16 μg/ml), Serratia marcescens (32 μg/ml), 
Escherichia coli, Staphylococcus aureus and Bacillus cereus 
(64μg/ml). Growth and aflatoxin production by toxigenic strains of 
Aspergillus were partially or completely inhibited by benzoic acid 
[20] and our data also support this evidence reported. Both 
fungistatic and fungicidal properties have been attributed to benzoic 
acid according to a result of a study involving several strains of 
Trichophyton and Microsporum [21]; however the present study 
recorded antifungal activity against Aspergillus flavus, Penicillum 
citrinum and Candida albicans with an MIC of 64 μg/ml. 
The partially purified subfraction (2) subjected to GC-MS contained 
9 compounds. Smaoui et al. [22] reported 1-nonadecene from 
Streptomyces sp. TN 256 strain exhibited antibacterial activity and 
strong antifungal activity against Candida albicans [23] and 1-
Tetradecene, 1-Hexadecene and cyclo tetracosane were reported 
from Gynura segetum's leaf extracts [24] showed potent 
antimicrobial activities. 5-Octadecene, 1-Hexadecene and 1-
nonadecene were compounds reported from Streptomyces sp. TN 
272, a novel terrestrial species isolated from soil and water samples 
of Tunisian regions [25]. A perusal of literature revealed that there 
was no report on the occurrence of 1-tetradecene, tetradecane, 
hexadecane, octadecane, 5-eicosene and cyclo tetracosane as natural 
products from microorganisms especially from actinomycetes, and 
this is the first report of their isolation from Streptomyces 
cheonanensis VUK-A. Identification of the compounds reported here 
is preliminary, and further structural analyses need to be performed 
to ascertain the identity of the compounds in the fourth subfraction. 
According to our antimicrobial studies the partially purified fourth 
sub-fraction possesses significant antibacterial as well as antifungal 
activities (table 1 and 2). 
CONCLUSION  
In the present study, the metabolites produced by Streptomyces 
cheonanensis VUK-A exhibited significant bioactivity against the test 
bacteria and fungi and reveals that the strain is promising producer 
of antimicrobial compounds. The compounds such as 1-tetradecene, 
tetradecane, hexadecane, octadecane, 5-eicosene and cyclo 
tetracosane identified by using GC-MS analysis are not yet reported 
from the genus Streptomyces and also as natural products from 
actinomycetes.  
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